You can Subscribe to our RSS FEED:
which delivers brain tumor news and additions
to the website via RSS.
Click HERE for details on RSS.
Displaying items 1 to 25 of about 5076
Midatech Pharma PLC Announces Headline Results of MTX110 Phase I DIPG Study
Musella Foundation Copayment Assistance Program Closed to New patients
What would YOU do if you were diagnosed with GBM?
Musella Foundation Copay Assistance Program Status
Brain TUmor Webinar Tonight!
Musella Foundation Copay Assistance Program is now open!
xCures announces the launch of a Compassionate Use program for ulixertinib (BVD-523)
Treatment Outcomes of Persistent Radiation-Induced Alopecia in Patients With Cancer
Cs-131 brachytherapy for patients with recurrent glioblastoma combined with bevacizumab avoids radiation necrosis while maintaining local control
2nd Annual Brain Tumor TOGETHER and ACTION Day
Medexus gets Health Canada nod to market tumor imaging material Gleolan for neurosurgery
New Webinar Added: Assessment of Treatment Response to Established and Novel Therapies in Glioblastoma Patients using Metabolic and Physiologic MR Imaging Techniques
Return to work following diagnosis of low-grade glioma
Glioblastoma Utilizes Fatty Acids and Ketone Bodies for Growth Allowing Progression during Ketogenic Diet Therapy
Prevention and Management of Dermatologic Adverse Events Associated With Tumor Treating Fields in Patients With Glioblastoma
GT Medical Technologies Announces Data Demonstrating Positive Local Control and Safety Outcomes with GammaTile Therapy for Large Brain Metastases
Phase I trial of convection-enhanced delivery of IL13RA2 and EPHA2 receptor targeted cytotoxins in dogs with spontaneous intracranial gliomas
The dopamine receptor antagonist trifluoperazine prevents phenotype conversion and improves survival in mouse models of glioblastoma
A phase 2 study of valproic acid and radiation, followed by maintenance valproic acid and bevacizumab in children with newly diagnosed diffuse intrinsic pontine glioma or high-grade glioma
Prognostic Value of ABO Blood Groups in Patients with Glioblastoma Multiforme
Ketone-Supressing Drug Combats Rare Brain Cancer in Mice
Northwell neurosurgeon first on Long Island to use Modus V™ 3D exoscope to remove brain tumor
ERC Announces Interim Results from Phase 2 Trial of Immunotherapy ERC1671 (Gliovac) in Recurrent Glioblastoma Patients
Amazon Smile Fundraiser! Action Required!
Promising Pathway Act Update.
Brain Tumor News Blast
Enter your email address to subscribe!
Copyright © 1993 - 2020 Musella Foundation- All Rights Reserved.
Website by LcsProductionDesign.com